CompletedNCT02147379
Cognition During Lurasidone Treatment for Bipolarity
About this title
Lurasidone and Cognition in Bipolar I Disorder
Read the official source — NCT02147379Medication studyAges 19–65Canada
Understand this study
Who was this study for?
Listed age limits: 19 years to 65 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 53
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT02147379
- Official title
Show the full official title
Changes in Cognitive Functioning in Euthymic Bipolar Patients Treated With Lurasidone Versus Treatment as Usual; A Randomized, Open-Label Study.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Did this study involve medication?
Yes. The study involved medication, including Lurasidone.
Who was this study for?
Listed age limits: 19 years to 65 years.
